← Zpět

402 ‒ NMR blood analysis: how mortality risk and more can be assessed from a single blood sample

Peter Attia MD

In this episode, Jim Otvos, Ph.D., recounts the unlikely story of transforming a flawed cancer test into a new way of measuring lipoproteins, explains what standard cholesterol tests can miss and why LDL-P and apoB can inform treatment decisions beyond LDL cholesterol alone, and dispels the misconception that large, “fluffy” LDL particles are benign. View show notes here: https://peterattiamd.com/jimotvos/ Become a member to receive exclusive content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ 0:00:00 - Intro 0:00:11 -

Peter’s current thoughts on rapamycin

This clip is from “Ask Me Anything” episode # 90 (Ep. # 411) of The Drive which was released on 10/12/26. In the full episode, we cover: -Why Peter still considers the ketogenic diet an effective tool

Why Peter changed his mind on Zone 2 training

This clip is from “Ask Me Anything” episode # 90 (Ep. # 411) of The Drive which was released on 10/12/26. In the full episode, we cover: -Why Peter still considers the ketogenic diet an effective tool

How Peter’s views have changed over the last 8 years

This clip is from “Ask Me Anything” episode # 90 (Ep. # 411) of The Drive which was released on 10/12/26. In the full episode, we cover: -Why Peter still considers the ketogenic diet an effective tool